Journal of Nuclear Medicine: 57 (5)

About the Cover

May 1, 2016; Volume 57,Issue 5

Cover image

Immuno-PET imaging of a CA125-targeting ⁸⁹Zr-labeled antibody may enhance the evaluation of high-grade serous ovarian cancer and provide a roadmap for surgery. See page 771.

In this issue

Issue highlights

Molecular Imaging Approaches for Supplemental Screening in Women at Increased Breast Cancer Risk
Comparing the Diagnostic Potential of ⁶⁸Ga-Alfatide II and ¹⁸F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis
Repeatability of Quantitative ¹⁸F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
Prospective Study of 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma

Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
⁶⁸Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the ⁶⁸Ga-FAPI PET Prospective Observational Trial
MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

More...

Main menu

User menu

Search

About the Cover

Cover image

In this issue

Issue highlights

Jump to